Chemoinformaics analysis of Monocaffeoyltartaric Acids
| Molecular Weight | 312.23 | nRot | 6 |
| Heavy Atom Molecular Weight | 300.134 | nRig | 10 |
| Exact Molecular Weight | 312.048 | nRing | 1 |
| Solubility: LogS | -1.093 | nHRing | 0 |
| Solubility: LogP | -0.368 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 7 | APOL | 36.9295 |
| nHD | 5 | BPOL | 16.3785 |
| QED | 0.146 |
| Synth | 3.248 |
| Natural Product Likeliness | 1.096 |
| NR-PPAR-gamma | 0.071 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.152 |
| HIA | 0.86 |
| CACO-2 | -6.201 |
| MDCK | 0.000258333 |
| BBB | 0.462 |
| PPB | 0.799891 |
| VDSS | 0.28 |
| FU | 0.24264 |
| CYP1A2-inh | 0.118 |
| CYP1A2-sub | 0.022 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.042 |
| CYP2c9-inh | 0.148 |
| CYP2c9-sub | 0.561 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.059 |
| CYP3a4-sub | 0.032 |
| CL | 3.007 |
| T12 | 0.963 |
| hERG | 0.011 |
| Ames | 0.01 |
| ROA | 0.012 |
| SkinSen | 0.322 |
| Carcinogencity | 0.065 |
| EI | 0.025 |
| Respiratory | 0.076 |
| NR-Aromatase | 0.018 |
| Antiviral | Yes |
| Prediction | 0.53878 |